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ABSTRACT 
In vertebrates, early brain development takes place 
at the expanded anterior end of the neural tube, 
which is filled with embryonic cerebrospinal fluid 
(E-CSF). We have recently identified a transient 
blood–CSF barrier that forms between embryonic 
days E3 and E4 in chick embryos and that is respon-
sible for the transport of proteins and control of 
E-CSF homeostasis, including osmolarity. Here we 
examined the presence of glucose transporter GLUT-1 
as well the presence of caveolae-structural protein 
Caveolin1 (CAV-1) in the embryonic blood-CSF bar-
rier which may be involved in the transport of glu-
cose and of proteins, water and ions respectively 
across the neuroectoderm. In this paper we demon-
strate the presence of GLUT-1 and CAV-1 in endo-
thelial cells of blood vessels as well as in adjacent 
neuroectodermal cells, located in the embryonic 
blood–CSF barrier. In blood vessels, these proteins 
were detected as early as E4 in chick embryos and 
E12.7 in rat embryos, i.e. the point at which the em-
bryonic blood–CSF barrier acquires this function. In 
the neuroectoderm of the embryonic blood-CSF bar-
rier, GLUT-1 was also detected at E4 and E12.7 re-
spectively, and CAV-1 was detected shortly thereafter 
in both experimental models. These experiments 
contribute to delineating the extent to which the 
blood–CSF embryonic barrier controls E-CSF com-
position and homeostasis during early stages of brain 
development in avians and mammals. Our results 
suggest the regulation of glucose transport to the 
E-CSF by means of GLUT-1 and also suggest a 
mechanism by which proteins are transported via 
transcellular routes across the neuroectoderm, thus 
reinforcing the crucial role of E-CSF in brain devel-
opment. 
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1. INTRODUCTION 
The microenvironment of the Central Nervous System 
(CNS) is decisive for neuronal development and func-
tion. After closure of the anterior neuropore, brain walls 
form a large and physiologically sealed cavity that en-
closes embryonic cerebrospinal fluid (E-CSF), a com-
plex and protein-rich fluid involved in several crucial 
roles in brain anlagen growth and development [1-8]. 
Chick and rat E-CSF proteomes analysed at E4 or HH23 
(following Hamburger and Hamilton, 1951) [9] and at 
E12.7, respectively, include molecules whose roles ex-
plain the general functions reported for this fluid [10-13], 
most of which is transported from the embryonic serum 
to the E-CSF [14]. Recently, we identified a transient 
blood–CSF barrier located in the brain stem lateral to the 
ventral midline, at the mesencephalon and prosencepha-
lon level, between embryonic days E3 and E5 in chick 
embryos and 12.7–13.7 days post-coitum in rats [15,16]. 
This embryonic blood–CSF barrier transports proteins 
in a selective manner via transcellular routes [15] as well 
as water and ions via specific transporters, identified by 
the presence of aquaporins 1 and 4 (AQP1 and AQP4) 
and the inwardly rectifying K+ channel (Kir4.1) [16]. 
Anatomically, this barrier is formed by specific blood 
vessels and the adjacent neuroectoderm, and, function-
ally, it controls E-CSF composition and homeostasis 
during this early stage of brain development, before the 
formation of functional choroid plexuses [15,16]. How-
ever, several questions regarding the embryonic 
blood–CSF barrier deserve further investigation, such as 
whether it also controls the transport of energetic mole-
cules for the developing CNS, namely glucose, and the 
mechanism by which protein, water and ions are trans-
ported across the neuroectoderm. In this regard, AQP1, 
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AQP4 and Kir4.1 have been identified solely in the 
blood vessels of the embryonic blood–CSF barrier, but 
not in the adjacent neuroectoderm [15], and proteins 
following transcellular routes have been visualized 
within the neuroectoderm [16]. 
Therefore, the analysis of the anatomical location of 
the glucose transporter GLUT-1 and the caveolae-structural 
protein Caveolin1 (CAV-1), both present in the adult 
blood-brain barrier (BBB) [17-19], for transcellular pro-
tein, water and ion transport, may provide new data on 
the embryonic blood-CSF barrier. CAV-1 (21–24 kDa), a 
member of the caveolin family of proteins, is the main 
structural component of caveolae, which are 50- to 
100-nm vesicular invaginations of the plasma membrane 
that are involved in transcellular molecular transport, as 
well as in cell adhesion and signal transduction. Endo-
thelial cells show the highest expression of CAV-1 [20], 
which is also found in the human BBB-provided vessels 
[21]. 
GLUT-1, an isoform of the glucose transporter (42–55 
kDa), is highly expressed by BBB microvessels and is 
localized in the endothelial plasma membrane but absent 
from circumventricular organs, which lack BBB proper-
ties [22-24]. Since glucose supports most cerebral func-
tions, the glucose requirements of the brain are high [22]. 
Thus, GLUT-1 plays a major role in brain metabolism 
since it is responsible for more than 90% of the glucose 
transport through the BBB. Thus, GLUT-1 immunoreac-
tivity has been detected in the neuroectoderm of devel-
oping brains of mice and rats from E9; however, it has 
been described that this expression progressively reduces 
as development proceeds, being finally restricted to in-
traneural capillaries [25-27]. Thus, according to Harik et 
al. [26], GLUT-1 immunoreactivity in rat neuroectoderm 
is no longer detected at E16, and according to Bauer et 
al. [27] this transporter is not detected in this tissue from 
E11 onwards in mice. These observations may reflect 
interspecific differences. 
Here we addressed these two BBB-specific markers to 
further analyse some of the molecular features of the 
embryonic blood–CSF barrier in avian (chick) and 
mammal (rat) in more detail, i.e. the existence of other 
known transporters as GLUT-1 and of caveolae vesicles. 
We demonstrate the presence of glucose transporter 
(GLUT-1) within the same blood vessels that exhibit 
barrier properties for proteins, water and ions, as visual-
ized by AQP1 co-detection, as well as in the transporting 
neuroectoderm adjacent to them. We also show that 
CAV-1 is also present in both the neuroectodermal and 
the endothelial cells that fulfil this barrier function, as 
shown by AQP1 co-detection. Our results contribute to 
delineating the extent to which the embryonic blood– 
CSF barrier controls E-CSF composition and homeosta-
sis and also elucidate the mechanism by which mole-
cules are transported across the neuroectoderm. The 
findings reported here reinforce the crucial role of 
E-CSF in brain development. 
2. MATERIAL AND METHODS 
2.1. Obtaining Chick and Rat Embryos 
Fertile chicken eggs (Gallus gallus; White-Leghorn strain) 
were incubated at 38°C in a humidified atmosphere to 
obtain embryos at the desired developmental stage, i.e. 
at E3 (HH20), E4 (HH23) and E5 (HH26) (E is for em-
bryonic day from the beginning of incubation; HH is for 
Hamburger and Hamilton developmental stages [9], as 
described in [24]. Rats (Rattus norvegicus; Wistar strain) 
were mated naturally. The morning of the appearance of 
a vaginal plug was designated as embryonic day 0.5 
(E0.5). Embryos at stages E12.7 and E13.7 were dis-
sected out from rats previously killed by CO2 asphyxia. 
Local animal welfare regulations were followed. 
2.2. SDS-Polyacrylamide Gel Electrophoresis 
and Western Blot Analysis 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed under denaturing conditions following 
the method described by Laemmli (1979) [28], with a 
Miniprotean II electrophoresis system (BioRad). Sam-
ples were obtained by homogenisation of brain stem 
tissues from dissected chick embryos obtained at E5, and 
from dissected rat embryos obtained at E13.7. Protein 
extracts from the dorsal mesencephalon were used as 
negative controls. At least five embryos were pooled for 
each stage, and the experiment was performed four times 
from separate protein collections. 
Molecular mass standards of high and low range (Bio-
Rad) were also used. SDS-PAGE was performed in a 
discontinuous buffer system for 40 min at 100 volts. 
Proteins were then electrotransferred (Trans-Blot Trans-
fer System, BioRad) from the SDS-PAGE to activated 
nitrocellulose membrane (Hybond-N) for 1 hr at 100 
volts, using a basic transfer buffer and following stan-
dard protocols. Proteins were immunodetected as de-
scribed in [15]. Welfare regulations were followed. 
2.3. PCR 
PCR analysis was performed on brain stems from chick 
embryos at E5 and rat embryos at E13.7 dissected under 
a dissecting microscope, and also on dorsal mesen-
cephalon as the negative control. The total mRNA was 
purified by the RNeasy Mini Kit for RNA extraction 
(Qiagen). The primers used are shown in Table 1. A re-
gime consisting of 94°C for 2 min (1 cycle), then 35 
cycles of 94°C for 1 min, 48°C for 30 s, and 72°C for 45 
s, followed by a single terminal extension step (72°C for  
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Table 1. Primers used for PCR analysis. 
Gene F/R Sequence (5’ to 3’) bp 
Chick 
F CACTGTTGTTTCGCTCTTCG 
GLUT-1 
R AATGTACTGGAAGCCCATGC 
316
F GCCCAATAACAAGATGATGGC 
CAV-1 
R GGATGCTGCACACCTTGC 
410
F CTACAATGAGCTGCGTGTGGC 275
B-Actin 
R CAGGTCCAGACGCAGGATGGC  
Rat 
F GCCTGAGACTTGAAAGAAC 
GLUT-1 
R CTGCTTAGGTAAAGTTACAGGAG
248
F GACTTTGAAGATGTGATTGC 
CAV-1 
R AGATGGAATAGACACGGCTG 
273
F CTACAATGAGCTGCGTGTGGC 
B-Actin 
R CAGGTCCAGACGCAGGATGGC 
275
 
5 min) on an Eppendorf Mastercycler was used for all 
primer sets. Actin was used as a positive control. Each 
PCR experiment was performed with four separate 
RNA-cDNA collections from five specimens for each 
stage. 100bp standards were used (Quimigen). Welfare 
regulations were followed. 
2.4. Immunohistochemistry 
To detect CAV-1 and GLUT-1 expression, chick embryos 
at E3 (HH20), E4 (HH23) and E5 (HH26) and rat em-
bryos at E12.7 and E13.7 were processed as described in 
[1]. These embryos were incubated with the corre-
sponding primary antibodies: rabbit anti-GLUT1 (Milli-
pore, AB1340) at 1/500; and rabbit anti-CAV1 (Beckton, 
C13630) at 1/500. Anti-rabbit conjugated to Alexa-488 
at 1/500 (Molecular Probes) was used as the secondary 
antibody. To simultaneously detect the area of GLUT-1 
and CAV-1 expression with respect to the previously 
described blood vessels involved in the blood-CSF, sev-
eral sections were immunostained with rabbit anti-CAV1 
or rabbit anti-GLUT1 and rabbit anti-AQP1 (Alpha Di-
agnostic), and the antibodies were then sequentially de-
tected with goat anti-rabbit conjugated to Alexa-488 at 
1/500 (Molecular Probes) for anti-AQP1 and goat 
anti-rabbit conjugated to Alexa-568 at 1/500 (Molecular 
Probes) for anti-GLUT1 and anti-CAV1. Half-mount 
embryos cut sagittally were also stained for GLUT-1 and 
CAV-1 expression.  
Immunostained sections were counterstained with 
phalloidin-TRITC at 1/2000 (Sigma, P1951) and/or with 
TOTO-3 at 1/1000 (Molecular Probes, T3604) in the 
presence of 1% Rnase (Sigma, R6513) as described in 
[15]. Photomicrographs were taken using a confocal 
microscope (Olympus) or with a dissecting microscope 
equipped with epifluorescence (Leica MZ16F), and were 
assembled with Photoshop software. 
3. RESULTS 
Immunochemical methods were used to determine the 
localisation of the caveolae-structural protein CAV-1 and 
the glucose transporter protein GLUT-1 in the head re-
gion of chick and rat embryos at early developmental 
stages. Examination of the head region included the area 
from the brachial arches level (i.e. approximately from 
the 5th somite) to all cephalic vesicles, thus comprising 
the entire brain primordium neuroectoderm as well as all 
surrounding tissues, i.e. the mesenchyma including the 
blood vessels within it, and the ectoderm. This area was 
selected on the basis of previous studies, in which blood 
vessels located in the brain stem lateral to the ventral 
midline, at the mesencephalon and prosencephalon level, 
were reported to form a blood–CSF barrier for proteins, 
water and ions. 
Chick embryos were examined from E3 (HH18) to E5 
(HH25), that is to say, just after closure of the anterior 
neuropore and before the initiation of neuroectodermal 
cavitation. Neither CAV-1 nor GLUT-1 was detected in 
E3 embryos (data not shown). In contrast, at E4, both 
CAV-1 and GLUT-1 immunostaining was detected in the 
endothelial cells of some blood vessels immersed in the 
mesenchyma in the brain stem, lateral to the ventral 
midline, at the mesencephalon and prosencephalon level, 
and close to the neuroectoderm. GLUT-1 was also ex-
pressed in the neuroectoderm close to these blood ves-
sels at both E4 and E5. However, CAV-1 expression in 
the neuroectoderm was not detected at E4 but shortly 
thereafter. The number of CAV-1 and GLUT-1 immuno-
reactive blood vessels and the intensity in the adjacent 
neuroectoderm increased in this region from E4 to E5, as 
development proceeded (Figure 1(a), (b)), and they 
were not clearly detected in other neuroectodermal areas 
of the head region. At these two stages, neither CAV-1 
nor GLUT-1 expression were detected in any other blood 
vessel or vascular sprout of the head region (Figure 
1(b)). 
To check whether blood vessels expressing CAV-1 
and GLUT-1 were the same as those involved in the pre-
viously reported embryonic blood-CSF barrier, double 
immunostaining with anti-CAV1 or alternatively anti- 
GLUT1 and with anti-AQP1 was performed (Figure 1(c)). 
AQP1 was chosen as it had previously been reported to  
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(a) 
 
(b) 
 
(c) 
Figure 1. Immunohistochemical localisation of CAV-1 and 
GLUT-1 in the head process of chick embryos at E4 and E5. A 
and C are merged confocal images (50 μm thick) of 200 μm 
vibratome sections. B is half-mount heads seen under a dis-
secting microscope. Note the immunoreactive blood vessels 
and vascular sprouts immersed within the parenchyma (arrows) 
and the staining within the neuroectoderm (arrowheads). In C), 
green arrows are for AQP1 green immunostaining; red arrows 
and arrowheads are for CAV-1 or GLUT-1 red immunostaining; 
and orange arrows are for areas simultaneously immunostained 
for AQP1 and CAV-1 or GLUT-1, which are seen in orange 
after merging. Nuclear counterstaining is shown in blue and 
cellular counterstaining in red (except in B). Scale bars: A: 0.1 
mm; B: 1 mm; C: 0.25 mm. Abbreviations: bc, brain cavity; d, 
diencephalon; m, mesencephalon; n, neuroectoderm; p, prosen- 
cephalon. 
be expressed in the same blood vessels fulfilling the 
blood-CSF function for proteins, and because its expres-
sion coincides with other molecular markers of this bar-
rier, namely AQP4 and Kir4.1. Embryos, which were 
examined at E5, showed the presence of CAV-1 and 
AQP1 or GLUT-1 and AQP1 in the same blood vessels. 
Certain areas of these blood vessels expressed both 
molecules (CAV-1/AQP1 or GLUT-1/AQP1) simultane-
ously while others expressed only one of them. However, 
these molecules were always located in the brain stem, 
lateral to the ventral midline, at the mesencephalon and 
prosencephalon level. 
To extrapolate the avian data to a mammalian system, 
we also examined the localisation of CAV-1 and 
GLUT-1 in rat embryos from E12.7 to E13.7, as these 
developmental stages are equivalent to those examined 
in chick embryos with respect to brain development. 
Thus, these stages correspond to the period between the 
closure of the anterior neuropore and the initiation of 
neuroectodermal cavitation, coincide with the starting 
period of maximum anterior CNS neurogenesis, and 
occur before the functional embryonic choroid plexus is 
formed. This strategy enabled us to determine whether 
mammals have a similar area with blood–CSF barrier 
functions. 
In rat embryos, CAV-1 and GLUT-1 were expressed at 
both E12.7 and E13.7 in the endothelial cells of some 
blood vessels located within the mesenchyma in the 
brain stem, lateral to the ventral midline, at the mesen-
cephalon and prosencephalon level, as well as in some 
vascular sprouts penetrating the neuroectoderm. With 
respect to neuroectodermal cells close to these blood 
vessels, GLUT-1 was detected at both E12.7 and E13.7. 
However, as in chick embryos CAV-1 expression was 
not detected at E12.7 but shortly thereafter (Figure 2). 
Again, at these two stages, CAV-1 and GLUT-1 expres-
sion was not detected in any other blood vessel or vas-
cular sprout of the head and immunostaining within the 
neuroecftoderm was not clearly detected in other neu-
roectodermal areas of the head region. 
Finally, to check the specificity of the immunodetec-
tion of CAV-1 and GLUT-1 in the brain stem of chick 
and rat embryos, we performed Western blot and PCR 
analysis on brain stem protein and RNA extracts respec-
tively, obtained from E5 chick and E13.7 rat embryos, as 
well as on extracts from the dorsal mesencephalon, as a 
negative control. The corresponding proteins and RNAs 
were detected in rat and chick brain stem extracts at the 
expected molecular mass and nucleotide length respec-
tively (Figure 3). 
4. DISCUSSION 
In adults, CSF composition and homeostasis is controlled  
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Figure 2. Immunohistochemical localization of CAV-1 and 
GLUT-1 in the head process of rat embryos at E12.7 and E13.7. 
Merged confocal image (50 μm thick) of 200 μm vibratome 
sections. Note the immunoreactive blood vessels immersed 
within the parenchyma (thick arrows), the immunoreactive 
vascular sprouts within the neuroectoderm (thin arrows) and 
the staining within the neuroectoderm (arrowheads), in green. 
Nuclear counterstaining is shown in blue and cellular counter-
staining in red. Last column shows a magnified area from the 
images of the middle column. Scale bars: 0.1 mm. Abbrevia-
tions: bc, brain cavity; n, neuroectoderm. 
 
by the choroid plexus and, to some extent, by BBB-pro-
vided vessels within the brain. The relevance of blood- 
to-brain and blood-to-CSF barriers for CNS develop-
ment is beginning to be elucidated, although little is 
known about early embryos. Recently, we demonstrated 
the presence of blood-barrier-forming vessels in chick 
and rat embryos, located in the brain stem, lateral to the 
ventral midline, at the mesencephalon and prosencepha-
lon level. The barrier properties develop between E3 
(HH18) and E4 (HH24) in chick embryos and at E12.7 
in rat embryos, the equivalent developmental stage in 
terms of brain vesicle formation. The blood vessels ex-
hibiting these properties, in conjunction with the neu-
roectoderm adjacent to them, provide an effective 
blood–CSF barrier for proteins as early as E4 in chick 
embryos [15], i.e. just after the closure of the neuropores,  
 
Figure 3. Western blot and PCR analysis of CAV-1 and 
GLUT-1 in the brain stem (+) of chick and rat embryos at E5 
and E13.7 respectively. Negative controls (-) for Western blot 
were made from the homogenized dorsal mesencephalon of 
chick and rat embryos at E5 and E13.7 respectively. Actin con-
trols for PCR are also shown. 
 
at a developmental stage at which the neural progenitor 
cells forming the brain wall exhibit both intense prolif-
eration and the initiation of a period characterized by a 
high rate of neurogenesis. 
Moreover, we also showed that channels for water 
(AQP1 and AQP4) and ion transport (inwardly rectifying 
K+ channel Kir4.1) were present in the same blood ves-
sels that carry out barrier functions for blood–CSF pro-
tein transport. This observation thus supports the hy-
pothesis that these blood vessels, together with the adja-
cent neuroectoderm, regulate E-CSF composition and 
homeostasis [16]. Interestingly, this area does not coin-
cide with the zones from which the adult choroid plex-
uses form in a subsequent developmental stage [24]. 
Later in development, during foetal stages, as well as in 
adults, choroid plexuses and BBB-provided vessels ex-
press a wide variety of specific transporters for a broad 
spectrum of molecules, ranging from proteins to glucose, 
amino acids, water and ions.  
Our findings show that GLUT-1, a glucose transporter, 
and CAV-1, which is present in caveolae transcellular 
transport in the adult BBB, are also in blood vessels lo-
cated in the embryonic blood–CSF barrier in chick and 
rat embryos at early stages of brain development. That is 
to say, they are present in blood vessels located in the 
brain stem, lateral to the ventral midline, at the mesen-
cephalon and prosencephalon level, where protein 
transport from embryonic serum to the E-CSF and vice 
versa has been described [13]. Moreover, the presence of 
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blood vessels expressing water and ion channel proteins 
(i.e. AQP1, AQP4 and Kir4.1) has been reported. Thus, 
double immunostained sections of chick embryos have 
shown that GLUT-1 and CAV-1 are expressed in the 
same blood vessels expressing AQP1, which in turn are 
those that express CAV-4 and Kir4.1, as previously re-
ported [16]. On the basis of our results and those from 
previous papers, we propose that in mammals these 
molecules may also be expressed in the same blood ves-
sels, namely those involved in the blood-CSF barrier. 
Moreover, GLUT-1 was also detected in the neuroec-
toderm involved in the embryonic blood–CSF barrier, 
thereby suggesting that glucose destined for developing 
brain cells is transported from the blood to the E-CSF by 
this glucose transporter. Of note, GLUT-1 was not de-
tected in any other location of the brain stem, thus indi-
cating the relevance of this barrier area for E-CSF com-
position control and homeostasis. Previous reports on 
GLUT-1 expression [25-27] indicate that this glucose 
transporter is expressed in mammals (mice in rat) from 
very early stages of brain development throughout the 
entire brain neuroectoderm, but that its expression de-
creases as development proceeds, becoming finally un-
detectable. In this regard, Dermietzel et al. [25] showed 
that the gradual decrease in GLUT-1 expression is not 
homogeneous in the neuroectoderm, and that this glu-
cose transporter becomes progressively restricted to 
some brain areas, including that involved in the 
blood-CSF barrier, as reported in this paper. 
Conversely, AQP1 and AQP4 for water transport, and 
Kir4.i for ion transport are present solely in these blood 
vessels [16], but not in the adjacent neuroectoderm. 
These observations therefore raise questions regarding 
the mechanisms by which they are transported through 
this tissue to reach the E-CSF. In this regard, protein 
transport has been reported to be transcellular [15], but 
no transcellular transporting structures have been de-
scribed. Our results demonstrate that CAV-1 is present in 
the blood vessels and the neuroectoderm forming the 
embryonic blood–CSF barrier. As caveolae are involved 
in transcellular transport, we propose that these are the 
structures by which proteins are transported from blood 
to E-CSF and vice versa. In addition, as caveolae may 
also transport water and ions alongside proteins, and 
neither water nor ion transporters have been identified in 
the embryonic blood–CSF barrier neuroectoderm, it is 
possible that these molecules, when outside the blood 
vessels, are transported by the caveolae to the E-CSF, 
along with transported proteins. However, the lack of 
functional data do not allow us to support this hypothesis. 
Finally, CAV-1 was not detected in any other location of 
the brain stem. This observation also indicates the rele-
vance of this barrier area for E-CSF composition control 
and homeostasis. It is also important to note that 
GLUT-1 and CAV-1 were detected at the same time as 
the development of protein barrier properties in chick 
embryos at E4, as previously reported [15].  
5. CONCLUSIONS 
Our results suggest that 1) glucose destined for the de-
veloping brain cells is transported from the blood to the 
E-CSF across endothelial and neuroectodermal cells that 
form the embryonic blood–CSF barrier via the GLUT-1 
glucose transporter; 2) proteins are transported across 
these embryonic tissues by CAV-1 caveolae–transcellular 
transport; and 3) water and ions, following transport out 
of the blood vessels by specific transporters, are taken by 
CAV-1 caveolae to be transported to the E-CSF along 
with proteins. Taken together, our results reinforce the 
hypothesis of an embryonic blood–CSF barrier in both 
avians and mammals that controls E-CSF composition 
and homeostasis, i.e. protein, water, ion and glucose 
transport, and acts before the formation of the choroid 
plexuses, thus contributing to the roles ascribed to the 
E-CSF in early brain development. 
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